Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1/STAT3 Signaling Pathway - Yun, Y; Chen, J; Wang, X (BioMed Research International, 2021)
et al.